Display options
Cite
Zhang L, Guo X, Min Y, et al. Tumor abnormal protein (TAP) examination contributes to primary diagnosis of bladder cancer. Int J Clin Exp Med. 2015;8(10):18528-32
Zhang, L., Guo, X., Min, Y., & Xu, J. (2015). Tumor abnormal protein (TAP) examination contributes to primary diagnosis of bladder cancer. International journal of clinical and experimental medicine, 8(10), 18528-32.
Zhang, Liqing, et al. "Tumor abnormal protein (TAP) examination contributes to primary diagnosis of bladder cancer." International journal of clinical and experimental medicine vol. 8,10 (2015): 18528-32.
Zhang L, Guo X, Min Y, Xu J. Tumor abnormal protein (TAP) examination contributes to primary diagnosis of bladder cancer. Int J Clin Exp Med. 2015 Oct 15;8(10):18528-32. eCollection 2015. PMID: 26770464; PMCID: PMC4694364.
Copy Download .nbib Format: NLM
Share it on

Int J Clin Exp Med. 2015 Oct 15;8(10):18528-32. eCollection 2015.

Tumor abnormal protein (TAP) examination contributes to primary diagnosis of bladder cancer.

International journal of clinical and experimental medicine

Liqing Zhang, Xiuxia Guo, Yongzheng Min, Jianjiang Xu

Affiliations

  1. Department of Urology Surgery, General Hospital of Jinan Military Command Jinan, China.
  2. Department of Gynecology, General Hospital of Jinan Military Command Jinan, China.
  3. Department of Pharmacy, General Hospital of Jinan Military Command Jinan, China.

PMID: 26770464 PMCID: PMC4694364

Abstract

OBJECTIVE: This study aims to investigate the application value of tumor abnormal protein (TAP) examination in the diagnosis of urothelial carcinoma of the bladder.

METHOD: Abnormal sugar chain glycoproteins in the peripheral blood of 87 patients with urothelial carcinoma of the bladder were detected, and compared with non-tumor patients accompanied by hematuria.

RESULT: TAP examination showed that the positive rate of the abnormal sugar chain glycoprotein in the peripheral blood of the 87 patients with urothelial carcinoma of the bladder was 78.16%, whereas that of the non-tumor patients was 10.81%. The former is significantly higher than the latter (P<0.01).

CONCLUSION: TAP examination can be used to detect urothelial carcinoma of the bladder, and would be helpful in the diagnosis of urothelial carcinoma of the bladder by combining the clinical signs and symptoms.

Keywords: Bladder; glycoprotein; tumor abnormal protein; urothelial carcinoma

References

  1. Gan To Kagaku Ryoho. 1986 Mar;13(3 Pt 2):747-53 - PubMed
  2. J Natl Compr Canc Netw. 2013 Apr 1;11(4):446-75 - PubMed
  3. Lik Sprava. 1997 Jan-Feb;(1):99-103 - PubMed
  4. Adv Urol. 2012;2012:397412 - PubMed
  5. Indian J Clin Biochem. 2014 Jul;29(3):345-50 - PubMed
  6. Int Urol Nephrol. 2015 Mar;47(3):473-7 - PubMed
  7. Urology. 2008 Nov;72(5):1159-63 - PubMed
  8. BMC Urol. 2015 Mar 13;15:15 - PubMed
  9. Nepal Med Coll J. 2014 Sep;16(1):9-12 - PubMed

Publication Types